Adherence to Integrative Care, Oncology Healthcare Utilization, Opioid Use and Hospitalization

Research on the relationship between integrative oncology (IO) programs and dispensing of chemotherapy agents and supportive care drugs, and hospitalization rates is limited. The present study examined these outcomes in chemotherapy-treated patients with cancer, comparing patients highly adherent to integrative care (high-AIC) to those with low adherence (low-AIC). Data from patients with cancer treated with taxane and/or platinum-based agents participating in an ongoing prospective, controlled pragmatic trial were examined retrospectively. Patients were referred to an IO consultation and weekly treatments at 3 medical centers in Northern Israel, with high-AIC defined as attending ≥4 sessions at 6 weeks; low-AIC, 0-3 sessions. Cancer-related parameters; dispensing of medication (chemotherapy agents, analgesics, anxiolytics and opioids); rates of hospitalizations and emergency room visits were analyzed using generalized linear regression models. Of 615 patients attending the IO consultation, 367 (59.7%) were high-AIC, with both groups having mostly similar baseline characteristics. Dispensing rates for taxanes (<i>P</i> = .336), platinum agents (<i>P</i> = .403), non-opioid analgesics (<i>P</i> = .201), and anxiolytics (<i>P</i> = .350), and number of emergency room visits were similar in both groups at 12 weeks. However, high-AIC patients had fewer dispensed opioid prescriptions (RR = 0.50, 95% CI = 0.30-0.85, <i>P</i> = .010); lower rates of hospitalization (OR = 0.59, 95% CI = 0.39-0.88, <i>P</i> = .010); and fewer hospitalization days (RR = 0.53, 95% CI = 0.31-0.90, <i>P</i> = .019). In conclusion, dispensing of chemotherapy drugs was similar between groups, though high-AIC patients used less opioids and had fewer hospitalizations at 12 weeks. Further research is needed with randomized and prospective studies exploring the relationship between adherence to IO care; adherence to chemotherapy; quality of life; opioid use; and hospitalization.

Authors

Institutions

Publication Details

Journal
Integrative Cancer Therapies
Published
2025-01-01
DOI
https://doi.org/10.1177/15347354251387955
Primary Topic
Medication Adherence and Compliance
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adherence to Integrative Care, Oncology Healthcare Utilization, Opioid Use and Hospitalization

Noah Samuels, Eran Ben‐Arye, Tzahit Simon‐Tuval, Ana Mariá López et al.
Integrative Cancer Therapies
Medication Adherence and Compliance
article

Adherence to Integrative Care, Oncology Healthcare Utilization, Opioid Use and Hospitalization

Noah Samuels, Eran Ben‐Arye, Tzahit Simon‐Tuval, Ana Mariá López, Dan Greenberg
article en

Abstract

Research on the relationship between integrative oncology (IO) programs and dispensing of chemotherapy agents and supportive care drugs, and hospitalization rates is limited. The present study examined these outcomes in chemotherapy-treated patients with cancer, comparing patients highly adherent to integrative care (high-AIC) to those with low adherence (low-AIC). Data from patients with cancer treated with taxane and/or platinum-based agents participating in an ongoing prospective, controlled pragmatic trial were examined retrospectively. Patients were referred to an IO consultation and weekly treatments at 3 medical centers in Northern Israel, with high-AIC defined as attending ≥4 sessions at 6 weeks; low-AIC, 0-3 sessions. Cancer-related parameters; dispensing of medication (chemotherapy agents, analgesics, anxiolytics and opioids); rates of hospitalizations and emergency room visits were analyzed using generalized linear regression models. Of 615 patients attending the IO consultation, 367 (59.7%) were high-AIC, with both groups having mostly similar baseline characteristics. Dispensing rates for taxanes (<i>P</i> = .336), platinum agents (<i>P</i> = .403), non-opioid analgesics (<i>P</i> = .201), and anxiolytics (<i>P</i> = .350), and number of emergency room visits were similar in both groups at 12 weeks. However, high-AIC patients had fewer dispensed opioid prescriptions (RR = 0.50, 95% CI = 0.30-0.85, <i>P</i> = .010); lower rates of hospitalization (OR = 0.59, 95% CI = 0.39-0.88, <i>P</i> = .010); and fewer hospitalization days (RR = 0.53, 95% CI = 0.31-0.90, <i>P</i> = .019). In conclusion, dispensing of chemotherapy drugs was similar between groups, though high-AIC patients used less opioids and had fewer hospitalizations at 12 weeks. Further research is needed with randomized and prospective studies exploring the relationship between adherence to IO care; adherence to chemotherapy; quality of life; opioid use; and hospitalization.

Integrative Cancer TherapiesVol. 24
Ben-Gurion University of the Negev (IL), Technion – Israel Institute of Technology (IL), Hebrew University of Jerusalem (IL), Shaare Zedek Medical Center (IL), Sidney Kimmel Cancer Center (US), Clalit Health Services (IL)
Openalex Percentile: Top 65%
Medication Adherence and Compliance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.